Morris & Dickson LLC Announces Strategic Partnership with Cost Plus Drug Company and Cost Plus Marketplace
On April 14, Morris & Dickson LLC, an independent pharmaceutical distributor, has announced a strategic partnership with the Mark Cuban Cost Plus Drug Company and the Cost Plus Marketplace to enhance national access to critical injectable medications.
The collaboration aims to tackle persistent drug shortages, particularly in acute care settings, by combining Cost Plus Drugs’ transparent, low-cost model with Morris & Dickson’s robust distribution network.
Key goals include ensuring a steady supply of hard-to-source injectables, improving affordability and access for healthcare providers of all sizes, and offering a streamlined ordering experience through the Cost Plus Marketplace, powered by GraphiteRx. Importantly, pharmacies can join the platform at no cost, with no minimum order requirements.
The initiative will begin with injectables but is expected to expand across a broader range of pharmaceuticals, promising long-term improvements in accessibility, pricing, and supply chain transparency.
Janette Wider | Editor-in-Chief
Janette Wider is Editor-in-Chief for Healthcare Purchasing News.
